GEN Exclusives

More »

GEN News Highlights

More »
Dec 5, 2007

BioSeek to Ally with UCB for Compound Evaluation

  • BioSeek and UCB will jointly evaluate a number of UCB compounds across several target classes in support of target differentiation, lead development, and drug candidate selection using BioSeek’s BioMAP® Systems.

    BioMAP Systems are a series of human primary cell-based assays designed to replicate cell and pathway interactions in human disease biology. BioMAP profiling provides characterization of drug function including defining mechanism of action and secondary activities and can provide insights into potential clinical applications, according to BioSeek.

    In addition to characterizing previously identified lead compounds, BioSeek is using BioMAP for primary screening to rapidly generate lead compounds that have novel activity in a particular disease setting.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Ebola Vaccines

When do you think an Ebola vaccine will be available for the general public?